April 2016
LCAO Issue Brief advocating for restoring Medicaid-level drug prices rebates for low-income Medicare beneficiaries who are dually eligible for Medicare and Medicaid and for beneficiaries with Extra Help.
Issue Briefs
LCAO Home Health Copayments Issue Brief
The updated issue brief outlines LCAO’s position and rational on any copayment proposal for Medicare home health services.
Medicare Beneficiary Characteristics and Out-of-Pocket Costs Issue Brief
An updated health issue brief on medicare beneficiary characteristics and out-of-pocket costs.
Social Security Disability Insurance (DI) Trust Fund Issue Brief
The Leadership Council of Aging Organizations has published an issue brief describing the importance of the Social Security Disability Insurance (DI) Trust Fund. The issue brief is primarily based on the testimony provided by Kate Lang, Income Security committee co-chair and Justice in Aging representative, before the Senate Budget committee on February 11th, 2015.
Medicaid Per Capita Caps Issue Brief
An updated issue brief outlining how a per capita cap, as some suggest in Congress, would spell danger for our country’s most vulnerable citizens.
Medicare Part D “Lock-in” Proposal Issue Brief
An LCAO Issue Brief on the Medicare Part D “Lock-In” Proposal Issue Brief to provide guidance on what beneficiary protections are important in any related future legislative proposal.
Medicare Therapy Cap Exceptions Process Should be Made Permanent Issue Brief
An updated issue brief from LCAO strongly urging Congress to include a permanent fix to the therapy cap exceptions process.
Reforming Medigap Plans By Shifting Costs Onto Beneficiaries Issue Brief
An updated health issue brief “Reforming Medigap Plans By Shifting Costs Onto Beneficiaries: A Flawed Approach to Medicare Savings”.
Building On What Works: Restoring Medicare Drug Rebates Issue Brief
An update to a previous issue brief on Medicare Drug Rebates.
Altering Extra Help Co-payments Issue Brief
The Leadership Council of Aging Organizations (LCAO) does not support increasing the Extra Help co-payment for brand name medications. Depending on the proposed increase in co-payments, the cost of medications could more than triple for some Extra Help beneficiaries, making needed prescriptions unaffordable.